Introduction
A blast wave includes a combination of the shock wave and the dynamic overpressure [1]. Primary blast injuries occur when the shock (stress) wave travels through the tissues, depositing energy, especially in organs with a gas-liquid interface [1]. Lungs, because of their special structure composed of air-filled alveoli harbouring a single layer of epithelial cells surrounded by delicate microvascular networks, represent susceptible organs to such a form of injury, the consequences of which are called blast lung injury [1]. The blast wave may cause instantaneous lung injury, characterised by alveolar capillary rupture and subsequent intrapulmonary haemorrhage and formation of pulmonary oedema [1]. If compared to lung contusions, to the much more extended and rather generalized physical impact of the blast wave to the thorax the pulmonary blast wave injury is usually a generalized acute lung injury causing alveolar ruptures at virtually the whole lung tissue. This is also evidenced by a characteristic bilateral, “butterfly” pattern in chest computer tomography, whereas lung contusions are usually unilateral, and more localized, as typically seen in vehicle accidents or falls from great heights [2].
The prognosis of trauma patients appears to be related to a post-traumatic immunologic imbalance status [3]. Systemic inflammatory response syndrome can occur when pro-inflammatory status is the dominant force. If the counter-regulatory and anti-inflammatory mediators predominate, immunosuppression (“immunoparalysis”) with an inconclusive elimination of microorganisms and septic complications may follow the procedure [4]. A host inflammatory response is necessary to orchestrate tissue repair and immune competence following severe trauma.
Blast exposure could induce inflammation, oxidative stress, and cell apoptosis in the lungs of experimental animals and humans [5]. Accordingly, the inflammatory response has been defined as an imbalance of signalling molecules and the pro- or anti-inflammatory profiles of subjects. Inflammatory responses are believed to perform a key role in the development of blast exposure-induced lung injury [6]. Blast limb trauma causes remote lung injury, which is likely associated with a remarkable inflammatory response, oxidative stress, and the depletion of protective mechanisms. Multiple factors, including TNF, IL-6, IL-1β and albumin protein in the BALF exacerbate lung tissue fibrosis and respiratory dysfunction following lower extremity blast trauma in rats [7, 8]. A robust and selective response of CD43Lo/His48Hi monocytes and neutrophils in blood and lung tissue following primary blast lung injury occurs [8].
Regardless of whether the chest trauma is blunt or penetrating, the risk of alveolar haemorrhage caused by ruptured alveoli and haemorrhage around pulmonary vessels in blast wave victims must always be considered [9]. A principal reason for preventable death as a result of an explosion could be haemorrhage [1]. Within minutes to hours after a millisecond to seconds of a blast wave, the alveolar wall ruptures with injury to the endothelial-based alveolar-interstitial and pneumocyte type I-dominated interstitial-alveolar membrane, causing scattered foci of alveolar bleeding, leading to accumulation of erythrocytes and proteinaceous blood serum deposits, and a much larger parenchymal laceration including emphysematous destruction or pneumothorax [10].
A comprehensive perception of the mechanisms underlying the cellular immune response to blast lung injury is of eminent importance, both in terms of disease prognosis and targeted futures in therapeutic aspects. Therefore, the current study, which involves establishing an experimental model of blast-induced lung injury in rats, aims to investigate the sequence of events as well as consecutive repair patterns over time and in comparison to non-blasted sham controls.
Materials and methods
2.1 Animals
The investigation conformed to recommendations published in the Guide for the Care and Use of Laboratory Animals (NIH publication No. 85–23, revised 1996) and was in accordance with the German legislation on the protection of animals. In all experiments female Wistar rats (Weight 230 ± 20 g; Harlan Winkelman GmbH, Borchen, Germany) were used. The animals were housed in a central, specific-pathogen-free animal housing facility under the oversight of the institutional animal welfare officer. The animals were fed standard rat chow and had access to water ad libitum until the start of the experiment. The study was approved by the Federal Animal Care and Use Committee in Tübingen, Germany.
2.2 Blast wave generator and pressure wave monitoring
The blast wave-induced lung injury model consisted of a standardised discharge of a pressure wave at a defined time point of the respiratory cycle. The magnitude of the pressure wave measured at the thorax level was in the range of what causes blast lung injury in humans [11]. A focal blast wave generator was used to deliver a reproducible blast wave injury in a laboratory environment simulating free air burst blast pressures by a detonation. The blast wave generator was originally designed by Irwin and co-workers and modified by the Liener team [12, 13] to discharge a reproducible blast pressure wave in a laboratory environment. A blast wave generator (Department of Scientific Engineering and Services, University of Konstanz, Germany) was used based on our specific needs in order to improve the pressure wave monitoring and the reproducibility of pressure wave exposure.
In brief, the blast wave generator consisted of a pressure reservoir, which was separated from the blast nozzle by an airtightly fixed polyester film (Strohmeier, Rheda-Wiedenbrück, Germany) that separated the two compartments (Fig 1A). A compressed air bottle was loaded to 18 bar. The computer-triggered opening of an ultra-fast industrial valve (HEE-D-MINI-24, opening time 25 ms, Festo AG & CO, Esslingen, Germany) between the compressed air bottle and the pressure reservoir resulted in an abrupt pressure rise and subsequent burst of the polyester diaphragm. Thus, a blast pressure wave was discharged through the nozzle towards the rat. Pressure sensors were located in the pressure reservoir and on each side of the rat’s thorax. An additional transducer recorded the breathing frequency and the respective breathing phase of the animal. Via this transducer, the valve was triggered automatically. The rats were anaesthetized in a bell jar flooded with a Halothane® (Sigma-Aldrich Chemie GmbH, Deisenhofen, Germany)/O2 gas mixture through a Halothane-evaporator (flow: 2 L/min oxygen, 4% Halothane). Then the animals were placed on a pad and positioned in a supine position, with the paws fixed by tape (Fig 1B). Up to the pressure wave exposure, they were maintained via an anaesthesia mask (flow: 1.5 L/min oxygen, 4% halothane). In addition, the animals received the analgesic Buprenorphine (Temgesic, Indivior Eu Ltd., Berkshire, Great Britain) (0.03 mg/kg BW) subcutaneously. Triggered by the breathing sensor, the rats were subjected to the pressure wave at the end of a tidal volume expiration. The blast pressure wave was centred on the xiphoid, with the tip of the blast nozzle located at a distance of 3.5 cm. Restauration of spontaneous breathing was recorded for one minute via the breathing sensor. Immediately after blast exposure, the animals were terminally anaesthetized by an intraperitoneal injection of sodium pentobarbital (Narcoren®, 160 mg/kg BW).
[Figure omitted. See PDF.]
A) Schematic diagram of the blast wave generator (front view). The dimension is in millimetres (mm). B) The blast wave generator includes pressure transducers at different positions. A cracking pressure transducer in the pressure reservoir, two overpressure sensors on the left and right sides of the rat and a transducer for recording the breathing frequency.
2.3 Bronchoalveolar Lavage (BAL)
Animals were randomly chosen and euthanized 10 min, 1.5 h, 3 h, 6 h, 12 h, 24 h, and 96 h after trauma (S1 Fig); non-traumatized animals served as sham controls. Lungs were tracheotomized and gently rinsed with 6 ml of ice-cold NaCl 0.9% solution (Delta-Pharma Boehringer-Ingelheim, Germany). Recovery of the instillate was always > 50%. In order to obtain BAL fluid (BALF) supernatant, BALF was centrifuged at 340 x g for 8 min, and the supernatants were stored at -70°C.
2.3.1 Determination of the alveolar haemorrhage.
Pulmonary haemorrhage was quantified using the total erythrocyte count in the BALF. The erythrocyte number was assayed in a Neubauer counting chamber.
2.3.2 Total and differential cell counts and cell viability.
To determine the total BAL cell count, BALF was mixed with Trypan Blue (Sigma-Aldrich Chemie GmbH, Deisenhofen, Germany) solution (1:2) and incubated for one minute at room temperature. The cell number was assayed using a Neubauer counting chamber. Cells that excluded the Trypan dye were regarded as viable, while blue cells were considered dead.
Cytospin preparations were used to determine the BAL cell differential. Depending on the total cell counts the BAL samples were first diluted (2–4 fold) in isolation medium before pipetting 200 μl into the cytospin inserts. The samples were centrifuged at 90 x g (Minifuge RF; Heraeus Instruments, Hanau, Germany) for 7 min. The cells were fixed and stained with May-Grünwald/Giemsa solution (Merck KGaA, Darmstadt, Germany). From every experiment, two cytospins were made, and a digital photograph was taken (Nikon Coolpix 995 through a customised ocular with a Zeiss Axiovert 50). The numbers of alveolar macrophages (AMs), lymphocytes, and infiltrated polymorphonuclear leukocytes (PMN) were assessed by using standard morphological criteria for differentiation.
Total blood leukocytes were determined in the Neubauer counting chamber by mixing heparin blood (Liquemin® in NaCl, 1:10) with Türk’s solution (1:10). For the differential blood count 10–15 μl whole blood were dispensed on a microscope slide, dried and stained with May-Grünwald/Giemsa solution.
2.3.3 Determination of total protein content.
The BAL supernatants were stored at -70°C. A standard 2 mg/ml bovine serum albumin (BSA) was diluted (2000, 1000, 500, 250, 125, 62.5, 31.25, 0 μg/ml). 10 μl sample and standard were added on a microtiter plate, respectively. 190 μl/well Pierce BCA protein assay reagent (Bender & Hobein GmbH, Heidelberg, Germany) was added and incubated for 30 min at 37°C. The extinction was measured at 550 nm in an ELISA reader. Protein content was calculated using the BSA standard curve.
2.3.4 Measurement of lactate dehydrogenase (LDH).
Lactate dehydrogenase (LDH) was measured in BALF according to the recommendations of the German Society for Clinical Chemistry. Measurement of LDH activity was performed in an Eppendorf ACP 5040 Analyser (Netheler & Hinz, Hamburg, Germany).
2.3.5 Cytokine determination.
For TNF measurements, samples were stored at –70°C and quantified by the sandwich enzyme-linked immunosorbent assay (ELISA). Antibody pairs (polyclonal rabbit anti-rat or anti-mouse) and recombinant TNF serving as standards were purchased from Pharmingen (San Diego, CA, USA). ELISA plates were coated overnight at 4°C with 50 μl/well with coat Ab (0.5% rabbit anti-TNF serum) diluted in coating buffer (1:200). After blocking with 200 μl/well of phosphate-buffered saline solution, PBS (PAA, Germany)/3% BSA at pH 7.0 for 2 h at room temperature, the plates were washed twice with PBS/0.05% (PAA, Germany) Tween 20 (Sigma-Aldrich Chemie GmbH, Deisenhofen, Germany). Samples and standard (50 μl/well) were added and incubated for 3 h. After four wash cycles, 100 μl/well 0.5 mg/ml tracer antibody in PBS/3% BSA were added and incubated for 45 minutes. After another six wash cycles, plates were incubated for 30 minutes with 100 μl/well 50 ng/ml streptavidin-peroxidase (Jackson Immuno Research, West Grove, PA, USA) in PBS/3% BSA. Following eight wash cycles, 100 μl/well TMB liquid substrate solution (Sigma, Deisenhofen, Germany) was added and incubated for 5–15 minutes. After addition of 50 μl/well stop solution (1 M H2SO4), absorption was measured at 450 nm using a reference wavelength of 690 nm in an ELISA reader. The detection limit of the assay was 10 pg/ml.
IL-10 and IL-6 were determined using a commercially available ELISA kit (Biosource Europe SA, Nivelles, Belgium). The detection limits of the assays were 15.6 pg/ml for IL-10 and 31 pg/ml for IL-6. Assay and analysis were performed according to the manufacturer’s recommendations.
2.3.6 Measurement of cytokine-induced neutrophil chemoattractant 3 (CINC-3).
Samples taken from BAL were stored at -20°C. The chemokine CINC-3 was assessed with the rat DuoSet ELISA Kit (R&D Systems Europe, Abingdon, UK) and performed according to the manufacturer’s recommendations.
2.3.7 Measurement of eicosanoid (thromboxane A2, 6-keto-PGF1α) concentrations.
BAL samples were stored at –70°C. Thromboxane A2 (t1/2 = 30 sec) was assessed as the stable by-product thromboxane B2 (TXB2). Both TXB2 and prostacyclin (6-keto-PGF1α) were determined by an EIA kit (BioTrend GmbH, Köln, Germany) according to the manufacturer’s instructions. The detection limits of the assays were 13.7 pg/ml TXB2 and 3.2 pg/ml 6-keto-PGF1α. The cross-reactivity of the detecting antibody was TXB2 100%, 2, 3—dinor TXB2 7.1%, prostaglandins<0.01% and 6-keto-PGF1α 100%, 2, 3-dinor 6-keto-PGF1α 3.17%, PGF2α 1.67%, prostaglandins 0.2–0.6%, respectively.
2.3.8 Gelatin zymography.
To detect the gelatinolytic activity of MMP-2 and -9 in BALFs, the samples of 3 to 5 animal per time point were evaluated by gelatin zymography as described previously [14]. In brief, 300 μl BAL fluid was concentrated by centrifuge. The supernatant was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis. After electrophoresis, the gels were incubated, fixed, and stained with 0.2% Coomassie brilliant blue R250 (Serva, Heidelberg, Germany). The gels were decolorized, and gelatin digestion was identified.
As markers, we used the purified pro-matrix metalloproteinase-2 (1 ng MMP-2, isolated from human rheumatoid synovial fibroblasts; Merck KGaA, Darmstadt, Germany) and pro-matrix metalloproteinase-9 (0.1 ng MMP-9, isolated from human neutrophil granulocytes; Merck KGaA, Darmstadt, Germany).
2.4 Wet to dry ratio of lung tissue
After the animal was sacrificed, the lungs were excised “en bloc” and cleaned of non-lung tissue and blood. The lung wet weight was determined before drying the lung tissue in an oven at 50°C. After three days, a stable dry weight of the lungs was achieved, and the wet to dry weight ratio was calculated.
2.5 Histological examinations
After thoracotomy and non-recirculating perfusion of the lung with PBS, the lung was excised, intratracheally infused with 4% buffered formalin (Sigma-Aldrich Chemie GmbH, Deisenhofen, Germany), and embedded in paraffin (Sigma-Aldrich Chemie GmbH, Deisenhofen, Germany). Five μm sections were stained with haematoxylin and eosin (Merck KGaA, Darmstadt, Germany) and examined by light microscopy.
2.6 Statistics
Data in the figures are given as means ± SEM, data in the tables as mean ± SD. Entire curves data from two experimental settings were compared by a two-way ANOVA design. Values of p<0.05 were considered statistically significant. Data from the end or other time points were analysed by one-way ANOVA. In case of differences among the groups, post-tests were performed as indicated in the legends (Dennett’s multiple comparison test, Tukey’s multiple comparison test, or Bonferroni’s multiple comparison test); statistics were performed with the Graph Pad Prism 3.0 software (Graph Pad Software, San Diego, CA, USA). Of note, we have done all the controls needed to use the parametric tests.
Results
3.1 Experimental timeline and blast model
Pressure curves over time measured by the transducers located on the right and left sides of the animal’s chest at the distance of 3.5 cm of the blast source to the thorax revealed a mean pressure peak of 3.16 ± 0.43 bar and a pressure wave duration of 630 ± 30 μs (n = 219). To improve reproducibility, animals were blasted in the same breathing state, i.e., during spontaneous tidal volume breathing under halothane anaesthesia at the end of expiration. Under these circumstances, overall mortality observed in all experiments was 14.5%., with most of the deaths appearing during the first minutes post-injury.
In the following sections, physiologic responses to thoracic trauma have been provided.
3.2 Lung blast injury temporarily disrupts the integrity of the alveolar-capillary barrier in rats
Within 10 minutes following blast pressure wave exposure, extensive alveolar haemorrhage and exudation of fluid into the interstitial and alveolar spaces were detectable, accompanied by a disruption of alveolar septae (Fig 2A). Three hours after blast exposure, there was a marked focal alveolar haemorrhage, while leukocyte infiltrates could not yet be detected (Fig 2B). Twenty four hours after the blast, erythrocyte-laden AMs were observed, accompanied by a few detectable PMN in the alveolar space (Fig 2C). Fig 2D and 2E represent the histological picture of the healthy normal lung tissue. Intra-alveolar haemorrhage, quantified by red blood cell counts (RBCs) in BALFs of traumatized rat lungs showed a significant increase within the first 10 minutes, but decreased after 6 h, in order to return to undetectable levels by 96 h after blast (Fig 3). As shown in Fig 4, a significant accumulation of protein occurred as early as 10 min following blast exposure in the alveolar space of traumatized lungs, as compared to non-traumatized controls (p<0.0001). After 24 h, protein levels decreased and 96 h following trauma protein concentration in BALF returned to control levels. The release of the cytosolic enzyme LDH into the BAL was used as a marker for cellular integrity following exposure to the blast. In conformity with the protein accumulation and RBC counts, LDH activity was remarkably elevated within ten min following pressure wave exposure (p<0.01) (Fig 5), but returned to control levels 96 h after the blast. Pulmonary injury, quantified by the lung wet to dry weight ratio (w/d lung weight ratio), was significantly enhanced within the initial 90 minutes following the blast (p<0.001), indicating pulmonary oedema formation At six hours the wet/dry ratio was significantly lower compared to 1.5 hours (p<0.001) (Fig 6).
[Figure omitted. See PDF.]
Rats were exposed to the pressure wave at 3.5 cm from the nozzle. Animals were sacrificed either 10 min A), 3 hours B) or 24 hours C) after blast exposure, non-traumatized animals served as sham controls E) + D). Visualized at an original magnification of 40-fold A)–C) + E) and 10-fold in D).
[Figure omitted. See PDF.]
Animals were sacrificed 10 min (n = 5), 1.5 h (n = 3), 3 h (n = 3), 6 h (n = 3), 12 h (n = 4), 24 h (n = 3) or 96 hours (n = 3) after blast exposure, non-traumatized animals served as sham controls (n = 9). Protein concentration was determined in the BALF. Data were analysed by one-way ANOVA and Dunnett’s multiple comparison test: **p <0.01 vs. control. Data represent means ± SEM, number of individual experiments (n) in parentheses.
[Figure omitted. See PDF.]
The animals were sacrificed 10 min (n = 5), 1.5 h (n = 3), 3 h (n = 3), 6 h (n = 3), 12 h (n = 3), 24 h (n = 3) or 96 hours (n = 3) after blast exposure, non-traumatized animals served as sham controls (n = 8). RBCs were determined in BALFs. Data were analysed by one-way ANOVA and Dunnett’s multiple comparison test: *p <0.05 and **p <0.01 vs. control. Data are means ± SEM, number of experiments (n) in parentheses.
[Figure omitted. See PDF.]
The animals were sacrificed 10 min (n = 5), 1.5 h (n = 3), 3 h (n = 3), 6 h (n = 3), 12 h (n = 4), 24 h (n = 3) or 96 hours (n = 3) after blast exposure, non-traumatized animals served as sham controls (n = 8). LDH activity was determined in BALFs. Data were analysed by one-way ANOVA and Dunnett’s multiple comparison test: *p <0.05 and **p <0.01 vs. control. Data are means ± SEM, number of experiments (n).
[Figure omitted. See PDF.]
Lung wet weight and dry weight were determined at different time-points after pressure wave exposure. The wet to dry weight ratios were calculated. Data were analysed by one-way ANOVA and Bonferroni’s multiple comparison test: **p <0.01 1.5 h vs. sham control and 6 h after blast, respectively.
3.3 Blast injury-induced release of inflammatory mediators
Since eicosanoids have been suggested to contribute to blast-related lung injury [15], we detected levels of thromboxane and prostacyclin in BALF at different time points following the blast. As shown in Fig 7A and 7B, a significant level of both thromboxane and prostacyclin was detected in BALF within 10 min ensuing blast pressure wave exposure (p<0.001), followed by a decrease by 90 min. At 96 h after blast exposure, we could no longer detect increased levels of these mediators.
[Figure omitted. See PDF.]
The animals were sacrificed 10 min (n = 6), 1.5 h (n = 3), 3 h (n = 3), 6 h (n = 3), 12 h (n = 4), 24 h (n = 3) or 96 hours (n = 3) after blast exposure, non-traumatized animals served as sham controls (n = 9). A) TxB2 release and B) 6-keto PGF1α were determined in BALFs. Data were analysed by one-way ANOVA and Tukey’s multiple comparison test. *** p <0.001: 10min vs. all other groups. Data represent means ± SEM, number of experiments (n) in parentheses.
3.4 Evolution of cytokine profile following blast wave exposure
Since both the inflammatory cytokines TNF and IL-6 have been shown to promote alveolar-capillary barrier dysfunction [16, 17], we examined their release into the BAL over time after blast injury. As shown in Fig 8A, increased TNF levels were detectable 3h after trauma (p<0.05 vs. control), reaching a maximum at 12h post blast exposure (p<0.01 vs. control). At later time-points, TNF levels continuously decreased (Fig 8A). In contrast, plasma TNF was not detectable at any time point up to 96 h after trauma, neither by ELISA nor by the WEHI-bioassay. IL-6 levels rose within 3h after trauma and reached significant peak levels after six hours (p<0.01 vs. control) (Fig 8B).
[Figure omitted. See PDF.]
The animals were sacrificed 10 min (n = 6), 1.5 h (n = 3), 3 h (n = 3), 6 h (n = 3), 12 h (n = 4), 24 h (n = 3) or 96 hours (n = 3) after blast exposure, non-traumatized animals served as sham controls (n = 9). A) TNF and B) IL-6 release were determined in BALFs. Data were statistically analysed by one-way ANOVA and Dunnett’s multiple comparison test: *p <0.05 and ** p <0.01 vs. sham control. Data represent means ± SEM, number of experiments (n) in parentheses.
Furthermore, IL-10 levels were measured in BALFs. In comparison to non-traumatized sham controls, the IL-10 levels in BALFs of traumatized animals were significantly decreased (p<0.01 and p<0.05, respectively) at any time-point within 24 h and increased to physiological levels/baseline 96 h after blast injury (Fig 9).
[Figure omitted. See PDF.]
The animals were sacrificed 10 min (n = 6), 1.5 h (n = 3), 3 h (n = 3), 6 h (n = 3), 12 h (n = 4), 24 h (n = 3) or 96 hours (n = 3) after blast exposure, non-traumatized animals served as sham controls (n = 9). IL-10 release was assessed in BALFs. Data were statistically analysed by one-way ANOVA and Dunnett’s multiple comparison test: *p<0.05 and **p<0.01 vs. sham control. Data are means ± SEM, number of experiments (n) in parentheses.
3.5 Release of soluble tumour necrosis factor receptors (sTNFR)
Because of the lack of detectable plasma TNF and the relatively moderate levels of TNF in the BAL after blast, we examined soluble tumour necrosis factor receptor type I (sTNFR-I) and soluble tumour necrosis factor receptor type II (sTNFR-II) levels in BALF in response to blast injury, in order to test whether the TNF is bound to its receptors and therefore not active and possibly not detectable. Patterns of BAL 55 kDa sTNFR-I and BAL 75 kDa sTNFR-II at serial intervals after injury are depicted in Fig 10A. In comparison to controls, both receptors were significantly elevated 90 minutes after the blast (p<0.01). Thereafter, levels declined, followed by a second marked increase within the first 6 to 12 h (p<0.01), and reaching near baseline levels within 24 h.
[Figure omitted. See PDF.]
Time course of sTNFR p55 and p75 BAL concentrations in A) as well as the p55/ p75 ratio in B). The animals were sacrificed 10 min (n = 6), 1.5 h (n = 3), 3 h (n = 3), 6 h (n = 3), 12 h (n = 4), 24 h (n = 3) or 96 hours (n = 3) after blast exposure, non-traumatized animals served as sham controls (n = 9). Levels of sTNFR p55 and p75 were assessed in BALFs. Data were analysed by one-way ANOVA and Dunnett’s multiple comparison test: *p <0.05 and **p <0.01 vs. sham control. Unpaired t-test was performed to compare differences in p55 and p75 levels at different time-points: **p = 0.0074 for p75 vs. p55 and *p = 0.04 for p75 versus p55 at 24 hours and 96 hours after blast, respectively. Data are means ± SEM, number of experiments (n) in parentheses. Linear regression between p55 and p75 release revealing a Pearson r of r = 0.96; p <0.0001.
Within the first 12 h after blast injury, there were no remarkable differences between sTNFR-I and sTNFR-II release. In contrast, 24 and 96 h after trauma the sTNFR-II levels were significantly higher than the sTNFR-I levels (p<0.01 and p<0.05, respectively). A comparison of the sTNFR-I and sTNFR-II levels of non-traumatized control lungs showed higher levels of sTNFR-II than of sTNFR-I (p<0.05). The sTNFR-I/II ratio was significantly elevated within 6 h of trauma compared to sham controls (p<0.05) and returned to reference ratios after 12 h (Fig 10B). A high correlation between both sTNFR subtypes could be shown over 96 h (r = 0.96; p<0.0001). The correlation between different detected plasma mediators revealed a correlation between both soluble TNF receptors and IL-6 levels over 96 h after blast exposure (r = 0.595; p<0.001 for sTNFR-I and r = 0.557; p<0.001 for sTNFR-II to IL-6, respectively).
3.6 Infiltration of inflammatory cells
3.6.1 PMN infiltration.
Analysis of the measure of various cell types in lavage fluids extracted from traumatized groups isolated at different time-points shows an increased number of neutrophils in BAL and as such, PMN migration into the alveolar space starting at 90 minutes following the blast. However, huge amounts of neutrophils were found not before 6 and 12 h after blast exposure (p<0.05 vs. sham controls) followed by a continuous decay within 96 h (Fig 11). The number of lymphocytes in the BALF did not vary significantly over time.
[Figure omitted. See PDF.]
The animals were sacrificed 10 min (n = 6), 1.5 h (n = 3), 3 h (n = 3), 6 h (n = 3), 12 h (n = 4), 24 h (n = 3) or 96 hours (n = 3) after blast exposure, non-traumatized animals served as sham controls (n = 9). Statistical analysis was performed by one-way ANOVA and Dunnett’s multiple comparison test: * p <0.05 vs. sham control. Data are expressed as mean ± SEM, number of experiments (n).
Fig 12A and 12B demonstrate the corresponding cytospins in the different BALFs. The cytospins of the non-traumatized sham controls exhibited a homogeneous population of AMs. Only very few lymphocytes could be found and no PMN (Fig 12A). At the time-point, 24 h post-blast injury, the PMNs showed about equal numbers compared to AMs. AMs were carrying high intracellular amounts of erythrocytes (Fig 12B). Quantitative analysis of peripheral blood leukocytes revealed no statistically significant differences within 96 h following blast exposure.
[Figure omitted. See PDF.]
A) sham control, B) 24 hours after blast exposure. AM: alveolar macrophages; Neu: neutrophils; Lym: lymphocytes; RBC: red blood cells.
Furthermore, significant increased neutrophil related myeloperoxidase (MPO) activity was determined in BALF investigated 12 after blast exposure as compared to non-traumatized controls (p<0.01) (0.43 ± 0.24 relative units, n = 4; and 0.07 ± 0,004 relative units, n = 9). Table 1 summarizes the time-dependent results of BALFs investigated after blast injury and in sham controls.
[Figure omitted. See PDF.]
3.6.2 CINC-3 measurement in the BALFs.
To illuminate the performance of chemokines in thoracic trauma-induced infiltration of neutrophils, we quantified the α-chemokine CINC-3 (also called macrophage inflammatory protein-2, MIP-2), which represents one of three functional rat homologues to human Interleukin 8 (IL-8). The CINC-3 levels in the BALFs of traumatized rat lungs were augmented 6 h after trauma (p<0.01 vs. sham controls) and rebounded to the level of sham control after 96 h. The time course of the CINC-3 release correlated with the neutrophils’ numbers (r = 0.63, p<0.001) (Fig 13).
[Figure omitted. See PDF.]
Non-traumatized animals served as sham controls (n = 9). Statistical analysis was performed by one-way ANOVA (p = 0.0014) and Dunnett’s multiple comparison test: **p <0.01 vs. sham control. Data are expressed as mean ± SEM, number of experiments (n).
3.6.3 Matrix metalloproteinases in the BALF
According to the observed neutrophil infiltration as well as extracellular matrix remodelling, we investigated the release and activation of the MMP-2, (72 kDa type IV collagenase or gelatinase A) and MMP-9 (92 kDa type IV collagenase, 92 kDa gelatinase or gelatinase B) over time after thoracic trauma. Gelatinolytic bands of approximately 134, 92, 85, 72, and 66 kDa were detected in BALFs. The bands correspond to the pro-MMP-9 lipocalin complex, pro-MMP-9, the active form of MMP-9, pro-MMP-2, and active form of MMP-2, respectively [14]. Intense gelatinolytic bands corresponding to MMP-9 and coexpressed bands of the pro-MMP-9 lipocalin complex were discovered after 6 h, and weak bands after 12 and 24 h, whereas lytic bands equivalent to active MMP-9 were only barely detected at these time-points. In addition, a weak gelatinolytic band corresponding to active MMP-9 appeared initially after trauma.
MMP-9 activity after 6 h correlated with the augmented neutrophil count in BAL at this time-point. MMP-2 is reported to be preferentially released by fibroblasts and epithelial cells and may, therefore, be generated after trauma-induced cellular injury.
Discussion
Blast thoracic injury seems to be the most dangerous type of non-penetrating thoracic injury that may more regularly lead to death due to acute lung injury than other non-penetrating thoracic injuries as in traffic accidents or by falls from a great height [2]. The lung, by virtue of its unique tissue architecture, is a blast-sensitive organ. Blast overpressure can physically destroy its vital compartments and induce inflammatory responses of varying degrees. Inflammatory responses are normally compartmentalised in the lungs, and the analysis of blood specimens provides an incomplete reflection of inflammatory events in the lungs [18]. As follows, we surveyed the presence or activity of mediators and inflammatory cells in the BALF of injured rat lungs versus sham controls in a defined set of blast-induced lung injuries in rats.
Obtained results demonstrated that following an initial blast-induced alveolar haemorrhage, the BAL red blood cell count, as well as the alveolar protein content, continuously reduced over time and both were no longer detectable after 96 h. This could be due to the elevated AMs amounts detected 96 h after the blast exposure. After haemorrhage, substantial quantities of haemoglobin or hemosiderin and ingested red blood cells in AMs can be detected. While peripheral blood leukocytes revealed no statistically significant differences after the blast injury in our setting, the AMs’ numbers increased starting 90 min after trauma and gained maximum level between 6 and 12 h in BAL. Significant protein accumulation in the alveolar space of traumatised lungs compared to sham controls confirms the disruption of the alveolar-interstitial and interstitial-alveolar barriers.
The LDH activity as a marker for cell damage varied in accordance with red blood cell counts and may therefore predominantly represent erythrocyte lysis; however, there is conceivably also cell death, apoptosis, or necrosis occurring in the alveolar septa, likely mostly including endothelial cells, interstitial cells, and alveolar type I cells. The increase in total protein content and alveolar haemorrhage together with an increase in the activity of LDH thus indicates both the disruption of the alveolar-capillary barrier and cell death. The concentration of eicosanoids in the BALFs revealed an immediate release after lung injury followed by a continuous decrease without a second increase. The inducible form of COX-2 could not be detected using RT-PCR in the BALFs within the first 6 h, suggesting that involvement of COX-2-dependent eicosanoids as mediators of a longer-standing inflammatory reaction is relatively unlikely.
MMP-9 was detectable in BALFs 6 h after blast exposure. MMP-9 is mostly expressed by inflammatory cells [19] and thus may be correlated with the observed neutrophil infiltration at this time. MMP-9 is a regulatory factor in neutrophil migration across the basement membranes [20] and involves equally in the degradation of the extracellular matrix [21]. The release and activation of MMP-2 were measurable within 24 h after the blast, whereas neither MMP-2 nor MMP-9 were detectable after 96 h and in BALF of non-traumatized rats. MMP-2 has been reported to be preferentially secreted by fibroblasts and epithelial cells [22] and may, therefore, be released after trauma-induced cell damage and participate in tissue remodelling.
6 h after trauma, IL-6 levels in BALF were found significantly elevated, as compared to non-traumatised control lungs and consequently returned back to their baseline value between 12 and 96 h after insult. This preliminary increase is in accordance with plasma IL-6 levels obtained from polytrauma patients [4, 23]. IL-6 generation is provoked at least partly by stimulation caused by TNF and IL-1β, and it has been proposed that IL-6 integrates early signals produced in the inflammatory response [24]. Some data support the concept that the production of TNF and IL-6 is regulated independently [25]. A crucial anti-inflammatory role for IL-6 through controlling the levels of other pro-inflammatory cytokines [26] and inducing the formation and release of sTNFR have been proposed [27]. IL-6 has been reported to be a marker of the intensity of the injury, as their local peak after blunt chest trauma coincided with the systemic inflammatory response accompanied by an impaired function of the pulmonary endothelial barrier [28] bearing some prognostic value for the survival in the preliminary posttraumatic phase [23].
In the current model, in addition to comparison to non-traumatized control lungs, the BAL TNF levels of traumatized lungs were significantly elevated from 3 h after trauma on and returned to basal values after 96 h. In a similar study with rats, up to a 10 fold BAL TNF level at 6 and 24 h after the blast exposure have been reported [29].
sTNFRs, even at low TNF concentrations, can affect TNF functions [30]. It is assumed that shedding of sTNFRs in response to high TNF concentrations could inhibit TNF activity and thus localise inflammatory response [31]. Moreover, disabling TNF proinflammatory action might facilitate anti-inflammatory action of TNF, which is mediated by its lectin-like domain [32–34]. We observed elevated sTNFR1 and 2 (p55 and p75) levels in rat lung BALFs within 90 minutes after trauma, analogous to plasma sTNFR levels of polytrauma patients [4, 35], suggesting that thorax trauma probably triggers the rapid release of receptors on the cell surface of injured lung tissue or activated leukocytes. Similar to the measured BAL TNF levels, BAL sTNFR1 and 2 levels were comparatively low as compared to plasma sTNFR1 and 2 levels observed in trauma patients [4, 36, 37]. Part of it may be explained by dilution due to the BAL, which is probably being about 100-fold [24]. In contrast to resembling studies [4, 36], we observed that receptor levels returned to non-traumatized control levels after 96 h, indicating a peak profile of sTNFR rather than a sustained elevation. Clinical studies reported decline of sTNFR levels in patients who recovered from injury [35], and accordingly the decrease in BAL sTNFR seems related to biologic recovery from primary blast injury. The correlation between each TNFRs with the IL-6 release within 96 h after blast supports the hypothesis that IL-6 may be involved in the regulation of both sTNFRs. Elevated sTNFR1 levels in cancer patients after administration of recombinant IL-6 have been also observed [27]. In the present study, the BAL levels of both sTNFRs were elevated within 90 minutes after trauma, which is in agreement with severely injured patients described previously [38]. An early shift towards sTNFR p55 release has been similarly reported [4]. Proteases and IL-6 have been discussed as the factors that may be responsible for the increased or prolonged release of sTNFR [27]. Neutrophil-derived proteases have been shown to be elevated, predominantly in patients with isolated thorax trauma [23]. The involvement of locally produced IL-6 in the early appearance of sTNFR subtypes in the injured lung after primary blast injury might be speculated. Whether sTNFR levels in BALFs represents the response to local TNF production and/ or the reason why BAL TNF levels were relatively moderate and plasma levels were even not measurable, cannot be explained by the present study.
At all time points studied up to 96 h after trauma, plasma TNF was below the detection limit, neither measurable by ELISA, nor functionally by the WEHI-bioassay. This underlines that TNF is mainly produced and secreted locally in the alveolar tissue, or by AMs. According to the biological importance of TNF, in ARDS patients on the first day, non-survivors had significantly higher BAL plasma ratios for TNF, IL-1β, IL-6, and IL-8, but also over time, BAL plasma ratios for TNF, IL-1ß, and IL-6 remained elevated in non-survivors, while they decreased in survivors [39].
IL-10 is an anti-inflammatory cytokine being produced by AMs [40]. IL-10 is assumed as a counter-regulatory cytokine that inhibits cytokine production by stimulated macrophages [41], is detectable in BALFs of ARDS patients in comparatively low concentrations (10–20 pg/ml) [24] and even significantly decreased levels over 24 h after blast exposure as compared to non-traumatized control lungs baseline levels, and normalized after 96 h. In the study of Liener et al. (2011), IL-10 as an indicator of anti-inflammatory regulation exhibited a diminishing tendency, compared to shame control [40]. Low IL-10 levels may introduce the function of this cytokine in the alveolar environment. In contrast, Hensler et al. (2002) found elevated plasma IL-10 values within 3 h after trauma in patients suffering from multiple injuries [4]. The lung perpetuates a constitutive level of anti-inflammatory cytokine IL-10, which is not enhanced after aerosol exposure of endotoxin, whereas systematically, intraperitoneal delivery of endotoxin resulted in an increase in circulating IL-10 [26]. Initiation of coagulation by tissue factor (TF) has been shown to be a powerful regulator of local inflammatory responses [42]. Accordingly, blockade of Tissue Factor-Factor VIIa complex protected the lung from injury by LPS in part by reducing local expression of pro-inflammatory cytokines and local elaboration of IL-1β, IL-6, and IL-10 [43]. Furthermore, trauma induces TF expression on monocytes have been discovered [44], which might be one reason for the observed decline in BAL IL-10 after blast injury in this model.
Thoracic trauma increased neutrophil chemokine production as shown in BAL with Cytokine-induced neutrophil chemoattractant 3 (CINC-3, MIP-2, GRO beta, or CXCL2), a member of the CXC subfamily of chemokines, peaking in the alveolar space about at 6 h. AMs are thought to be the major source of α-chemokines such as CINC-3 in the airspaces [24, 45] and produce CINC e.g. in response to LPS in vitro [46] and in vivo [45, 47, 48]. CINC-3 has been reported to play the most important role in the recruitment of neutrophils and their activation during lipopolysaccharide- mediated ALI [47]. Lung injury by large tidal volume ventilation demonstrated increased IL-8 levels in BALF originating mainly from neutrophils accumulated in the lung [49]. In chronic inflammation induced by experimental pulmonary silicosis, CNC-3 was shown to be a chemoattractant in the formation of granulomas [50]. In contrast, the level of CINC-3 was shown to be low in experimental chronic bronchopulmonary infections of rats with Pseudomonas aeruginosa [51], and after experimental airway exposure of rats to staphylococcal enterotoxin [52] indicating the important role of the causative agent damaging the lung tissue and initiating the inflammatory response concerning CINC-3.
The reduced wet/dry ratio assessed 3 and 6 h after the blast, as compared to the immediately assessed lungs can be related to both reduced oedema generation and elevated oedema resorption. Whether these effects are related to possible endogenous epinephrine-induced actions or to actions due to the lectin-like tip region of TNF cannot be explained as we did not specifically attempt to block possible trauma-related epinephrine or TNF lectin-like region effects. These results suggest that sodium channels are at least in part functional after blast injury in this model [33, 34]. Thus, increased alveolar fluid clearance might be an underlying mechanism for the postulated fluid resorption in vivo within the first six hour after trauma. Indeed the rise in wet/dry ratio at 15 minutes is solely due to intra-alveolar haemorrhage, while the rise of this ratio at 3 hours could be due to both haemorrhage and oedema.
The model and the presented results are associated with many limitations. The in vivo model is a rather standardized severe trauma model in which about a tenth of rats died, and is therefore done with minimal numbers of animals per group or time point and thus with restricted biosamples. Thoracic trauma deteriorates lung function, leading to a certain degree of respiratory failure, which has mainly been indirectly shown here as e.g. in terms of wet-dry ratio. The effect of anaesthetics like halothane and the opioid buprenorphine cannot be excluded, but also pain might be a potential modifier of outcome. In the experimental setting the use of sham controls may best correct for those effects. The present study established a blast-induced lung injury model in rats, which provides rather valid and reproducible results. The experimental data complement those from human patients and may once give avenues to modulating injury, which is of importance in view of the impact of trauma on all, but especially also on young patients and thus on society. In addition to the time-dependent resolution of the trauma-related alveolar protein-rich fluid, these results gave evidence of the high and rapid repair including the alveolar fluid, cell, and cell debris clearance capacity of the lung. Furthermore, it is unclear whether shorter and possibly more representative duration blast over pressure related injuries are distinct from longer and more frequent duration blast over pressure related injuries.
Supporting information
S1 Fig. Timeline of the experiment.
https://doi.org/10.1371/journal.pone.0281446.s001
(PPT)
S1 File. The ARRIVE essential 10.
https://doi.org/10.1371/journal.pone.0281446.s002
(DOC)
Acknowledgments
This work has mainly been performed by Dr. Katja Eichert as work on her thesis; all authors highly acknowledge her work for this paper. In addition, we acknowledge the collaboration of Ulrich Liener, Markus Knöferl, Florian Gebhard, Lothar Kinzl (Univ. of Ulm), Manfred Kind (Department of Pathology, Konstanz), and the technical assistance of Bruno Erne (Technical Dept., Univ. of Konstanz), Clemens Braun, Anne Hildebrandt and Sandra Unger (Univ. of Konstanz).
Citation: Hamacher J, Hadizamani Y, Huwer H, Moehrlen U, Bally L, Stammberger U, et al. (2023) Characteristics of inflammatory response and repair after experimental blast lung injury in rats. PLoS ONE 18(3): e0281446. https://doi.org/10.1371/journal.pone.0281446
About the Authors:
Jürg Hamacher
Roles: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
E-mail: [email protected]
Affiliations: Pneumology, Clinic for General Internal Medicine, Lindenhofspital, Bern, Switzerland, Lungen-und Atmungsstiftung, Bern, Switzerland, Medical Clinic V—Pneumology, Allergology, Intensive Care Medicine, and Environmental Medicine, Faculty of Medicine, Saarland University, University Medical Centre of the Saarland, Homburg, Germany, Institute for Clinical & Experimental Surgery, Faculty of Medicine, Saarland University, Homburg, Germany
Yalda Hadizamani
Roles: Project administration, Writing – review & editing
Affiliations: Pneumology, Clinic for General Internal Medicine, Lindenhofspital, Bern, Switzerland, Lungen-und Atmungsstiftung, Bern, Switzerland
ORICD: https://orcid.org/0000-0002-6285-4912
Hanno Huwer
Roles: Conceptualization, Data curation, Methodology, Software, Writing – original draft
Affiliations: Department of Cardiothoracic Surgery, Völklingen Heart Centre, Völklingen, Germany, Department of Human Genetics, Saarland University, Homburg, Saar, Germany, Department of Thoracic and Cardiovascular Surgery of the University Hospital of Saarland, Homburg, Saarland, Germany
Ueli Moehrlen
Roles: Writing – review & editing
Affiliations: Lungen-und Atmungsstiftung, Bern, Switzerland, Pediatric Surgery, University Children’s Hospital Zurich, Zurich, Switzerland
Lia Bally
Roles: Writing – review & editing
Affiliation: Department of Diabetes, Endocrinology, Clinical Nutrition and Metabolism Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland
Uz Stammberger
Roles: Investigation, Methodology, Supervision, Validation, Writing – review & editing
Affiliations: Lungen-und Atmungsstiftung, Bern, Switzerland, STM ClinMedRes Consulting, Basel, Switzerland
Albrecht Wendel
Roles: Validation
Affiliation: Biochemical Pharmacology, Department of Biology, University of Konstanz, Konstanz, Germany
Rudolf Lucas
Roles: Formal analysis, Investigation, Methodology, Supervision, Validation, Writing – review & editing
Affiliations: Vascular Biology Center, Augusta University, Augusta, GA, United States of America, Department of Pharmacology and Toxicology, Augusta University, Augusta, GA, United States of America, Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, United States of America
ORICD: https://orcid.org/0000-0003-3805-8868
1. Smith J.E. and Garner J., Pathophysiology of primary blast injury. J R Army Med Corps, 2019. 165(1): p. 57–62. pmid:30317218
2. Explosions and blast injuries: a primer for clinicians. Centers for Disease, Control Prevention.
3. Guirao X. and Lowry S.F., Biologic control of injury and inflammation: much more than too little or too late. World J Surg, 1996. 20(4): p. 437–46. pmid:8662132
4. Hensler T., et al., Association between injury pattern of patients with multiple injuries and circulating levels of soluble tumor necrosis factor receptors, interleukin-6 and interleukin-10, and polymorphonuclear neutrophil elastase. J Trauma, 2002. 52(5): p. 962–70. pmid:11988666
5. Liu M. and Lei B., Pathogenesis of Hypervirulent Group A Streptococcus. Jpn J Med (Lond), 2018. 1(6): p. 269–275. pmid:30556051
6. Liu Y., et al., CD28 Deficiency Ameliorates Blast Exposure-Induced Lung Inflammation, Oxidative Stress, Apoptosis, and T Cell Accumulation in the Lungs via the PI3K/Akt/FoxO1 Signaling Pathway. Oxidative medicine and cellular longevity, 2019. 2019: p. 4848560–4848560. pmid:31565151
7. Ning J.L., et al., Lung injury following lower extremity blast trauma in rats. J Trauma Acute Care Surg, 2012. 73(6): p. 1537–44. pmid:23064609
8. Barnett-Vanes A., et al., CD43Lo classical monocytes participate in the cellular immune response to isolated primary blast lung injury. J Trauma Acute Care Surg, 2016. 81(3): p. 500–11. pmid:27306447
9. Tsokos M., et al., Histologic, immunohistochemical, and ultrastructural findings in human blast lung injury. Am J Respir Crit Care Med, 2003. 168(5): p. 549–55. pmid:12842857
10. Mackenzie I., et al., What the Intensive Care Doctor Needs to Know about Blast-Related Lung Injury. Journal of the Intensive Care Society, 2013. 14(4): p. 303–312.
11. DePalma R.G., et al., Blast injuries. N Engl J Med, 2005. 352(13): p. 1335–42. pmid:15800229
12. Liener U.C., et al., Induction of apoptosis following blunt chest trauma. Shock, 2003. 20(6): p. 511–6. pmid:14625474
13. Irwin R.J., et al., Global primary blast injury: a rat model. J Okla State Med Assoc, 1998. 91(7): p. 387–92. pmid:9793276
14. Suga M., et al., Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am J Respir Crit Care Med, 2000. 162(5): p. 1949–56. pmid:11069839
15. Cernak I., et al., Leukotrienes in the pathogenesis of pulmonary blast injury. J Trauma, 1996. 40(3 Suppl): p. S148–51. pmid:8606397
16. Hamacher J., et al., Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med, 2002. 166(5): p. 651–6. pmid:12204860
17. Lucas R., et al., Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. Biochem Pharmacol, 2009. 77(12): p. 1763–72. pmid:19428331
18. Nelson S., et al., Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J Infect Dis, 1989. 159(2): p. 189–94. pmid:2644368
19. Segura-Valdez L., et al., Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest, 2000. 117(3): p. 684–94. pmid:10712992
20. Keck T., et al., Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. Gastroenterology, 2002. 122(1): p. 188–201. pmid:11781293
21. Whiteside E.J., et al., Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 are key regulators of extracellular matrix degradation by mouse embryos. Biol Reprod, 2001. 64(5): p. 1331–7. pmid:11319136
22. Murphy G. and Docherty A.J., The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol, 1992. 7(2): p. 120–5. pmid:1497900
23. Gebhard F., et al., Untersuchungen zur systemischen posttraumatischen Inflammation in der Frühphase nach Trauma. 1 ed. Hefte zur Zeitschrift "Der Unfallchirurg". 2000: Springer-Verlag Berlin Heidelberg.
24. Martin T.R., Lung cytokines and ARDS: Roger S. Mitchell Lecture. Chest, 1999. 116(1 Suppl): p. 2S–8S. pmid:10424558
25. Roumen R.M., et al., Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg, 1993. 218(6): p. 769–76. pmid:8257227
26. Xing Z., et al., IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest, 1998. 101(2): p. 311–20. pmid:9435302
27. Tilg H., et al., Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood, 1994. 83(1): p. 113–8. pmid:8274730
28. Perl M., et al., The pulmonary and hepatic immune microenvironment and its contribution to the early systemic inflammation following blunt chest trauma. Crit Care Med, 2006. 34(4): p. 1152–9. pmid:16484915
29. Liener U.C., et al., Does blunt chest trauma alter the function of alveolar Macrophages? Shock, 2002. 18: p. 16.
30. Aderka D., et al., Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med, 1992. 175(2): p. 323–9. pmid:1310100
31. Mohler K.M., et al., Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol, 1993. 151(3): p. 1548–61. pmid:8393046
32. Lucas R., et al., Mapping the lectin-like activity of tumor necrosis factor. Science, 1994. 263(5148): p. 814–7. pmid:8303299
33. Hamacher J., et al., Cytokine–Ion Channel Interactions in Pulmonary Inflammation. Frontiers in Immunology, 2017. 8: p. 1644. pmid:29354115
34. Lucas R., et al., Dichotomous Role of Tumor Necrosis Factor in Pulmonary Barrier Function and Alveolar Fluid Clearance. Frontiers in Physiology, 2022. 12. pmid:35264975
35. Cinat M.E., et al., Trauma causes sustained elevation of soluble tumor necrosis factor receptors. J Am Coll Surg, 1994. 179(5): p. 529–37. pmid:7952454
36. Ertel W., et al., Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome. J Trauma, 1995. 39(5): p. 879–85; discussion 885–7. pmid:7474003
37. Keel M., et al., [Increased plasma level of Type I (p55) and Type II (p75) TNF-receptors following trauma]. Swiss Surg, 1995(5): p. 241–4.
38. Tan L.R., et al., Trauma causes early release of soluble receptors for tumor necrosis factor. J Trauma, 1993. 34(5): p. 634–8. pmid:8388481
39. Meduri G.U., et al., Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest, 1995. 108.
40. Liener U.C., et al., Is the function of alveolar macrophages altered following blunt chest trauma? Langenbecks Arch Surg, 2011. 396(2): p. 251–9. pmid:20393744
41. Fiorentino D.F., et al., IL-10 inhibits cytokine production by activated macrophages. J Immunol, 1991. 147(11): p. 3815–22. pmid:1940369
42. Welty-Wolf K.E., et al., Tissue factor in experimental acute lung injury. Semin Hematol, 2001. 38(4 Suppl 12): p. 35–8. pmid:11735108
43. Miller D.L., et al., Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide. Am J Respir Cell Mol Biol, 2002. 26(6): p. 650–8. pmid:12034563
44. Utter G.H., et al., Injury induces increased monocyte expression of tissue factor: factors associated with head injury attenuate the injury-related monocyte expression of tissue factor. J Trauma, 2002. 52(6): p. 1071–7; discussion 1077. pmid:12045632
45. Shanley T.P., et al., Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury. J Immunol, 1997. 158(7): p. 3439–48. pmid:9120305
46. Dong W., Lewtas J., and Luster M.I., Role of endotoxin in tumor necrosis factor alpha expression from alveolar macrophages treated with urban air particles. Exp Lung Res, 1996. 22(5): p. 577–92. pmid:8886760
47. Yamasawa H., Ishii Y., and Kitamura S., Cytokine-induced neutrophil chemoattractant in a rat model of lipopolysaccharide-induced acute lung injury. Inflammation, 1999. 23(3): p. 263–74. pmid:10392760
48. Kang J.L., et al., Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. Am J Respir Crit Care Med, 2001. 164(12): p. 2206–12. pmid:11751189
49. Kotani M., et al., Neutrophil depletion attenuates interleukin-8 production in mild-overstretch ventilated normal rabbit lung. Crit Care Med, 2004. 32(2): p. 514–9. pmid:14758172
50. Hata J., et al., Change in location of cytokine-induced neutrophil chemoattractants (CINCs) in pulmonary silicosis. Exp Mol Pathol, 2003. 75(1): p. 68–73. pmid:12834627
51. Amano H., et al., Role of cytokine-induced neutrophil chemoattractant-2 (CINC-2) alpha in a rat model of chronic bronchopulmonary infections with Pseudomonas aeruginosa. Cytokine, 2000. 12(11): p. 1662–8. pmid:11052817
52. Desouza I.A., et al., Inflammatory mechanisms underlying the rat pulmonary neutrophil influx induced by airway exposure to staphylococcal enterotoxin type A. Br J Pharmacol, 2005. 146(6): p. 781–91. pmid:16170330
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2023 Hamacher et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Background and objectives
Blast-induced lung injury is associated with inflammatory, which are characterised by disruption of the alveolar-capillary barrier, haemorrhage, pulmonary infiltrateration causing oedema formation, pro-inflammatory cytokine and chemokine release, and anti-inflammatory counter-regulation. The objective of the current study was to define sequence of such alterations in with establishing blast-induced lung injury in rats using an advanced blast generator.
Methods
Rats underwent a standardized blast wave trauma and were euthanised at defined time points. Non-traumatised animals served as sham controls. Obtained samples from bronchoalveolar lavage fluid (BALF) at each time-point were assessed for histology, leukocyte infiltration and cytokine/chemokine profile.
Results
After blast lung injury, significant haemorrhage and neutrophil infiltration were observed. Similarly, protein accumulation, lactate dehydrogenase activity (LDH), alveolar eicosanoid release, matrix metalloproteinase (MMP)-2 and -9, pro-Inflammatory cytokines, including tumour necrosis factor (TNF) and interleukin (IL) -6 raised up. While declining in the level of anti-inflammatory cytokine IL-10 occurred. Ultimately, pulmonary oedema developed that increased to its maximum level within the first 1.5 h, then recovered within 24 h.
Conclusion
Using a stablished model, can facilitate the study of inflammatory response to blast lung injury. Following the blast injury, alteration in cytokine/chemokine profile and activity of cells in the alveolar space occurs, which eventuates in alveolar epithelial barrier dysfunction and oedema formation. Most of these parameters exhibit time-dependent return to their basal status that is an indication to resilience of lungs to blast-induced lung injury.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer